Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)'s share was trading at $67.74 as of May 12^th. NVO’s trailing and forward P/E were 19.18 and 16.50 respectively according to Yahoo Finance.

[caption id="attachment_652071" align="aligncenter" width="750"] Pixabay/Public Domain[/caption]

Novo Nordisk delivered a robust Q1 performance, marked by a 19% increase in revenue in Danish kroner (18% at constant exchange rates) to DKK 78.1 billion and a 22% rise in...